Wednesday, 30 September 2009

Penicillamine




In some countries, this medicine may only be approved for veterinary use.


In the US, Penicillamine (penicillamine systemic) is a member of the drug class antirheumatics and is used to treat Cystinuria, Rheumatoid Arthritis and Wilson's Disease.

US matches:

  • Penicillamine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M01CC01

CAS registry number (Chemical Abstracts Service)

0000052-67-5

Chemical Formula

C5-H11-N-O2-S

Molecular Weight

149

Therapeutic Categories

Disease-modifying antirheumatic drug, DMARD

Antidote: Treatment of heavy metal poisoning

Chelating agent

Treatment of Wilson's disease

Chemical Name

D-Valine, 3-mercapto-

Foreign Names

  • Penicillaminum (Latin)
  • Penicillamin (German)
  • Pénicillamine (French)
  • Penicilamina (Spanish)

Generic Names

  • Penicillamina (OS: DCIT)
  • Penicillamine (OS: JAN, USAN, BAN)
  • Pénicillamine (OS: DCF)
  • ß-Mercaptovaline (IS)
  • Penicillamin (PH: Ph. Eur. 6)
  • Penicillamine (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Pénicillamine (PH: Ph. Eur. 6)
  • Penicillaminum (PH: Ph. Int. 4, Ph. Eur. 6)
  • Penicillamine Hydrochloride (PH: BP 1973)

Brand Names

  • Adalken
    Kendrick, Mexico


  • Artamin
    Biochemie, United Arab Emirates; Biochemie, Jordan; Biochemie, Kuwait; Biochemie, Lebanon; Biochemie, Qatar; Biochemie, Saudi Arabia; Biochemie, Sudan; Biochemie, Yemen; Sandoz, Austria; Sandoz, Oman


  • Atamir
    Sandoz, Denmark; Sandoz, Iceland


  • Cilamin
    Panacea, India


  • Cuprenil
    Kutno, Bulgaria; Polfa, Bulgaria; Polfa Kutno, Lithuania; Polfa Kutno, Poland; Teva, Latvia


  • Cuprimine
    Aton, United States; Aton Pharma, Canada; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Peru; Merck Sharp & Dohme, Thailand; Merck Sharp & Dohme, Taiwan


  • Cupripen
    Inmunosyn, Colombia; Omedir, Argentina; Rubio, Spain


  • Cupripren
    Bestpharma, Chile


  • Depen
    Meda, United States


  • Distamin
    Samarth, India


  • Distamine
    Alliance, United Kingdom; Alliance, Ireland


  • Distamine (veterinary use)
    Alliance, United Kingdom


  • D-Penamine
    Alphapharm, Australia; Pacific, New Zealand


  • D-Penil
    AC Farma, Peru


  • Mercaptyl
    Abbott, Switzerland


  • Metalcaptase
    Harvester, Taiwan; Heyl, Czech Republic; Heyl, Germany; Heyl, Luxembourg; Taisho Yakuhin, Japan


  • Penicillamine Ifet
    IFET, Greece


  • Penicillamine
    Generics, Malta


  • Trolovol
    Dexo, France


  • Pemine
    Lilly, Italy

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 20 September 2009

Capisten




Capisten may be available in the countries listed below.


Ingredient matches for Capisten



Ketoprofen

Ketoprofen is reported as an ingredient of Capisten in the following countries:


  • Japan

International Drug Name Search

Lentocaine




Lentocaine may be available in the countries listed below.


Ingredient matches for Lentocaine



Mepivacaine

Mepivacaine hydrochloride (a derivative of Mepivacaine) is reported as an ingredient of Lentocaine in the following countries:


  • Mexico

International Drug Name Search

Saturday, 19 September 2009

CiL




CiL may be available in the countries listed below.


Ingredient matches for CiL



Fenofibrate

Fenofibrate is reported as an ingredient of CiL in the following countries:


  • Germany

International Drug Name Search

Friday, 18 September 2009

Simvastatina Lareq




Simvastatina Lareq may be available in the countries listed below.


Ingredient matches for Simvastatina Lareq



Simvastatin

Simvastatin is reported as an ingredient of Simvastatina Lareq in the following countries:


  • Spain

International Drug Name Search

Wednesday, 16 September 2009

Growject




Growject may be available in the countries listed below.


Ingredient matches for Growject



Somatropine

Somatropine is reported as an ingredient of Growject in the following countries:


  • Japan

International Drug Name Search

Friday, 11 September 2009

Robitussin CoughGels


Pronunciation: DEX-troe-meth-OR-fan
Generic Name: Dextromethorphan
Brand Name: Examples include DexAlone and Robitussin CoughGels


Robitussin CoughGels is used for:

Temporarily relieving cough due to the common cold, upper respiratory tract infections, sinus inflammation, sore throat, or bronchitis.


Robitussin CoughGels is a cough suppressant. It works by loosening mucus and lung secretions in the chest and making coughs more productive.


Do NOT use Robitussin CoughGels if:


  • you are allergic to any ingredient in Robitussin CoughGels

  • you are taking or have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Robitussin CoughGels:


Some medical conditions may interact with Robitussin CoughGels. Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, plan to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have chronic cough, chronic bronchitis or any breathing problems, such as asthma, emphysema, chronic obstructive pulmonary disease (COPD), or if cough occurs with a large amount of mucus

Some MEDICINES MAY INTERACT with Robitussin CoughGels. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Furazolidone or MAO inhibitors (eg, phenelzine) because the risk of toxic side effects may be increased by Robitussin CoughGels

This may not be a complete list of all interactions that may occur. Ask your health care provider if Robitussin CoughGels may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Robitussin CoughGels:


Use Robitussin CoughGels as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Robitussin CoughGels may be taken with or without food. Take with food if stomach upset occurs.

  • If you miss a dose of Robitussin CoughGels and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Robitussin CoughGels.



Important safety information:


  • Robitussin CoughGels may cause drowsiness, dizziness, blurred vision, or lightheadedness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Robitussin CoughGels. Using Robitussin CoughGels alone, with certain other medicines, or with alcohol may lessen your ability to drive or to perform other potentially dangerous tasks.

  • If your cough lasts for more than 1 week or comes back, or if you also have a fever, rash, or persistent headache, contact your health care provider. A persistent cough could be a sign of a serious condition.

  • Robitussin CoughGels contains dextromethorphan. Before you being taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains dextromethorphan. If it does or if you are not sure, contact your health care provider or pharmacist.

  • Phenylketonuria patients - Robitussin CoughGels contains phenylalanine.

  • Robitussin CoughGels is not recommended for use in CHILDREN younger than 2 years of age. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you are pregnant or plan on becoming pregnant, discuss with your doctor the benefits and risks of using Robitussin CoughGels during pregnancy. It is unknown if Robitussin CoughGels is excreted in breast milk. Do not breast-feed while taking Robitussin CoughGels.


Possible side effects of Robitussin CoughGels:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; drowsiness; stomach upset.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Robitussin CoughGels side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; excitement; hallucinations; slowed breathing.


Proper storage of Robitussin CoughGels:

Store Robitussin CoughGels between 59 and 86 degrees F (15 and 30 degrees C), away from heat, moisture, and light. Do not store in the bathroom. Keep Robitussin CoughGels out of the reach of children and away from pets.


General information:


  • If you have any questions about Robitussin CoughGels, please talk with your doctor, pharmacist, or other health care provider.

  • Robitussin CoughGels is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Robitussin CoughGels. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Robitussin CoughGels resources


  • Robitussin CoughGels Side Effects (in more detail)
  • Robitussin CoughGels Use in Pregnancy & Breastfeeding
  • Robitussin CoughGels Drug Interactions
  • Robitussin CoughGels Support Group
  • 0 Reviews for Robitussin CoughGels - Add your own review/rating


  • Robitussin CoughGels Concise Consumer Information (Cerner Multum)

  • Creo-Terpin Advanced Consumer (Micromedex) - Includes Dosage Information

  • Dextromethorphan Hydrobromide Monograph (AHFS DI)



Compare Robitussin CoughGels with other medications


  • Cough

Thursday, 10 September 2009

Mediplast




In the US, Mediplast (salicylic acid topical) is a member of the following drug classes: topical acne agents, topical keratolytics and is used to treat Acne and Warts.

US matches:

  • Mediplast

  • Mediplast Topical

Ingredient matches for Mediplast



Salicylic Acid

Salicylic Acid is reported as an ingredient of Mediplast in the following countries:


  • United States

International Drug Name Search

Wednesday, 9 September 2009

rabies vaccine Intramuscular


RAY-beez VAX-een


Commonly used brand name(s)

In the U.S.


  • Imovax Rabies

  • Rabavert

Available Dosage Forms:


  • Injectable

  • Powder for Solution

  • Powder for Suspension

Therapeutic Class: Vaccine


Uses For rabies vaccine


Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.


Rabies vaccine is used in two ways. Rabies vaccine is given to persons who have been exposed (e.g., by a bite, scratch, or lick) to an animal that is known, or thought, to have rabies. This is called post-exposure prophylaxis. Rabies vaccine may also be given ahead of time to persons who have a high risk of getting infected with rabies virus. These persons include veterinarians, animal handlers, or travelers who will spend more than 1 month in countries having a high rate of rabies infection, and persons who live, work, or take vacations in wild areas of the country where they are likely to come into contact with wild animals. This is called pre-exposure prophylaxis.


Rabies infection is a serious, and often fatal, infection. In the U.S., rabies in wild animals, especially raccoons, skunks, and bats, accounts for most cases of rabies passed on to humans, pets, and other domestic animals. In Canada, the animals most often infected with rabies are foxes, skunks, bats, dogs, and cats. Horses, swine, and cattle also have been known to become infected with rabies. In much of the rest of the world, including Latin America, Africa, and Asia, dogs account for most cases of rabies passed on to humans.


If you are being (or will be) treated for a possible rabies infection while traveling outside of the U.S. or Canada, contact your doctor as soon as you return to the U.S. or Canada, since it may be necessary for you to have additional treatment.


This vaccine is to be administered only by or under the supervision of your doctor or other health care professional.


Before Using rabies vaccine


In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to rabies vaccine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


This vaccine is not expected to cause different side effects or problems in children than it does in adults.


Geriatric


Many vaccines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of rabies vaccine in the elderly with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this vaccine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Receiving this vaccine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Chloroquine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Illness, severe, with fever—The symptoms of the condition may be confused with the possible side effects of the vaccine.

  • Immune deficiency condition, or family history of—May decrease the useful effects of the vaccine.

Proper Use of rabies vaccine


You will receive this vaccine while you are in a hospital or clinic. A nurse or other trained health professional will give you this vaccine. The vaccine is injected into the upper arm muscle (deltoid). Very young or small children may have the vaccine injected into the upper leg (thigh) muscle.


In order for the rabies vaccine to work properly, it is very important that you do not miss any doses. Keep your appointments with your doctor.


Dosing


The dose of rabies vaccine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rabies vaccine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For post-exposure prophylaxis if you have never received rabies vaccine before:
      • Adults and children—One dose on the first day after rabies exposure (day 0), then one dose three, seven, and fourteen days later for a total of four doses. On the first day, you will also receive an injection of the rabies immune globulin.

      • Adults and children with an immune system problem will need five doses of the vaccine. The last dose is given twenty-eight days after the first dose.


    • For post-exposure prophylaxis if you have received rabies vaccine before:
      • Adults and children—One dose on the first day, then one dose three days later for a total of two doses.


    • For pre-exposure prophylaxis if you have never received rabies vaccine before:
      • Adults and children—One dose on the first day, then one dose seven and twenty-one or twenty-eight days later for a total of three doses. The vaccine is injected into, or under the skin of, the muscle (deltoid) in the upper arm. Very young or small children may have the vaccine injected into the upper leg (thigh) muscle.


    • For pre-exposure prophylaxis if you have received rabies vaccine before (also known as a booster dose):
      • Adults and children—One dose injected into, or under the skin of, the muscle (deltoid) in the upper arm. Very young or small children may have the vaccine injected into the upper leg (thigh) muscle.



Missed Dose


Call your doctor or pharmacist for instructions.


Precautions While Using rabies vaccine


It is very important that your doctor check your progress at regular visits to make sure that this vaccine is working properly.


This vaccine may cause some people to become dizzy. Make sure you know how you react to this vaccine before you drive, use machines, or do anything else that could be dangerous if you are dizzy.


rabies vaccine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


Rare
  • Hives or skin rash

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Chills

  • dizziness

  • fever

  • general feeling of discomfort or illness

  • headache

  • itching, pain, redness, or swelling at the place of injection

  • muscle or joint aches

  • nausea

  • stomach or abdominal pain

  • tiredness or weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

Loteprednol Etabonate




Loteprednol Etabonate may be available in the countries listed below.


Ingredient matches for Loteprednol Etabonate



Loteprednol

Loteprednol Etabonate (BANM, USAN) is known as Loteprednol in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 5 September 2009

Ipramol Steri-Nebs




Ipramol Steri-Nebs may be available in the countries listed below.


Ingredient matches for Ipramol Steri-Nebs



Ipratropium

Ipratropium Bromide is reported as an ingredient of Ipramol Steri-Nebs in the following countries:


  • Switzerland

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Ipramol Steri-Nebs in the following countries:


  • Switzerland

International Drug Name Search

Thursday, 3 September 2009

Actapam




Actapam may be available in the countries listed below.


Ingredient matches for Actapam



Indapamide

Indapamide is reported as an ingredient of Actapam in the following countries:


  • Slovakia

International Drug Name Search

Wednesday, 2 September 2009

Losartan Merck




Losartan Merck may be available in the countries listed below.


Ingredient matches for Losartan Merck



Losartan

Losartan is reported as an ingredient of Losartan Merck in the following countries:


  • Slovenia

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Merck in the following countries:


  • Portugal

  • Spain

International Drug Name Search